Insertion/deletion polymorphism of the angiotensin-converting enzyme gene and loss of the insertion allele in aldosterone-producing adenoma

Journal of Human Hypertension

Volumn 10, Issue 12, 1996, Pages 827-830

  Tunny, T J ^a   Xu, L ^a   Richardson, K A ^a   Stowasser, M ^a   Gartside, M ^a   Gordon, R D ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Aldosterone producing adenoma; Angiotensin converting enzyme gene; Insertion deletion polymorphism; Primary aldosteronism

Indexed keywords

ALDOSTERONE; DIPEPTIDYL CARBOXYPEPTIDASE;

ADRENAL CORTEX ADENOMA; ARTICLE; CARCINOGENESIS; CHROMOSOME 17Q; CONTROLLED STUDY; DNA POLYMORPHISM; GENE DELETION; GENE FREQUENCY; GENE INSERTION; HUMAN; MAJOR CLINICAL STUDY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TUMOR SUPPRESSOR GENE;

ADENOMA; ADRENAL GLAND NEOPLASMS; ALLELES; GENE DELETION; HUMANS; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA;

EID: 0030436915     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Gordon RD, Klemm SA, Tunny TJ, Stowasser M. Primary aldosteronism: hypertension with a genetic basis. Lancet 1992; 340: 159-161.
2. Gordon RD, Stowasser M, Klemm SA, Tunny TJ. Primary aldosteronism-some genetic, morphological and biochemical aspects of subtypes. Steroids 1995; 60: 35-41.
3. Klemm SA et al. Detection of renin mRNA by polymerase chain reaction in aldosterone-producing adenoma. J Hypertens 1993; 11 (Suppl 5): S302-S303.
4. Yagi A et al. Aldosterone response to adrenocorticotrophin and furosemide in primary aldosteronism after prolonged spironolactone treatment. Eur J Endocrinol 1994; 131: 215-220.
5. Klemm SA et al. The renin gene in aldosterone-producing adenomas. Kidney Internat 1994; 46: 1591-1593.
6. Tunny TJ et al. Association of restriction length polymorphism at the atrial natriuretic peptide gene locus with aldosterone-responsiveness to angiotensin in aldosterone-producing adenoma. Biochem Biophys Res Commun 1994; 204: 1312-1317.
7. Mattei MG, Hubert C, Alhene GF. Angiotensin I converting enzyme gene on chromosome 17. Cytogenetics Cell Genet 1989; 51: 1041.
8. Rigat B et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enyzme levels. J Clin Invest 1990; 80: 1343-1346.
9. Lifton RP et al. A chimaeric 11β-hydroxylase/ aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 1992; 355: 262-265.
10. Stowasser M et al. Hybrid gene or hybrid steroids in the detection and screening for familial hyperaldosteronism type I. Clin Exper Pharmacol Physiol 1995; 22: 444-446.
11. Lachurie ML et al. Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects. Circulation 1995; 91: 2933-2942.
12. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucl Acid Res 1992; 20: 1433.
13. Jeunemaitre X. Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nat Genet 1992; 1: 72-75.
14. Harrap SB et al. The angiotensin-converting enzyme gene and predisposition to high blood pressure. Hypertension 1993; 21: 455-460.
15. Barley J et al. Angiotensin-converting enzyme gene I/D polymorphism, blood pressure and the renin-angiotensin system in Caucasian and Afro-Caribbean peoples. J Hum Hypertens 1996; 10: 31-35.
16. Johnson AG et al. I/D polymorphism of the angiotensin-converting enzyme gene does not predict isolated systolic or systolic-diastolic hypertension in the elderly. J Hum Hypertens 1996; 10: 167-169.
17. Zee RY, Lou YK, Griffiths LR, Morris BJ. Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertension. Biochem Biophys Res Commun 1992; 184: 9-15.
18. Duru K et al. Frequency of a deletion polymorphism in the gene for angiotensin converting enzyme is increased in African-Americans with hypertension. Am J Hypertens 1994; 7: 759-762.
19. Cambien F et al. Deletion polymorphism in the gene for angiotensin converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-644.
20. Leatham E et al. Angiotensin-1 converting enzyme (ACE) polymorphism in patients presenting with myocardial infarction or unstable angina. J Hum Hypertens 1994; 8: 635-638.
21. Murakami YS, Brothman AR, Leach RJ, White RL. Suppression of malignant phenotype in a human prostate cancer cell line by fragments of normal chromosomal region 17q. Cancer Res 1995; 55: 3389-3394.
22. Gao X et al. Localization of potential tumor suppressor loci to a <2Mb region on chromosome 17 in human prostate cancer. Oncogene 1995; 11: 1241-1247.
23. Fong KM et al. Loss of heterozygosity frequently affects chromosome 17q in non-small cell lung cancer. Cancer Res 1995; 55: 4268-4272.
24. Borresen AL. Oncogenesis in ovarian cancer. Acta Obstet Gynecol Scand 1992; 155: 25-30.
25. Wertheim I et al. Loss of heterozygosity of chromosome 17 in human borderline and invasive epithelial ovarian tumors. Oncogene 1996; 12: 2147-2153.
26. Vagner-Capodano AM et al. Cytogenetic studies in 45 pediatric brain tumors. Pediatr Hematol Oncol 1992; 9: 223-235.
27. Gutmann DH et al. Loss of neurofibromin in adrenal gland tumors from patients with neurofibromotosis type 1. Genes Chromosomes Cancer 1994; 10: 55-58.